These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1973518)

  • 1. Genetic counselling for cystic fibrosis based upon mutation/haplotype analysis.
    Watson E; Williamson B; Brueton L; Winter R
    Lancet; 1990 Jul; 336(8708):190-1. PubMed ID: 1973518
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutation and linkage disequilibrium analysis in genetic counselling of Spanish cystic fibrosis families.
    Casals T; Nunes V; Lázaro C; Giménez FJ; Girbau E; Volpini V; Estivill X
    J Med Genet; 1991 Nov; 28(11):771-6. PubMed ID: 1770534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis transmembrane regulator haplotypes in households of patients with cystic fibrosis.
    Furgeri DT; Marson FAL; Correia CAA; Ribeiro JD; Bertuzzo CS
    Gene; 2018 Jan; 641():137-143. PubMed ID: 29054758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of 112 haplotypes carrying the cystic fibrosis gene. Applications in genetic counseling].
    Parent P; Ferec C; Morin JF; Chabaud JJ
    J Genet Hum; 1989 Jun; 37(2):133-40. PubMed ID: 2746172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fertile male with cystic fibrosis: molecular genetic analysis.
    Barreto C; Pinto LM; Duarte A; Lavinha J; Ramsay M
    J Med Genet; 1991 Jun; 28(6):420-1. PubMed ID: 1870100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal detection of major cystic fibrosis mutation.
    Halley DJ; van Damme NH; Deelen WH; Oostra BA; Jahoda MG; Sachs ES; Los FJ; Niermeijer MF
    Lancet; 1989 Oct; 2(8669):972. PubMed ID: 2571875
    [No Abstract]   [Full Text] [Related]  

  • 7. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An at-risk pregnancy of a carrier of cystic fibrosis (mucoviscidosis) with a new partner].
    Reiss J; Krawczak M; Gal A; Zerres K; Kaiser R; Weber J
    Monatsschr Kinderheilkd; 1989 Aug; 137(8):451-3. PubMed ID: 2811875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification refractory mutation system for prenatal diagnosis and carrier assessment in cystic fibrosis.
    Newton CR; Heptinstall LE; Summers C; Super M; Schwarz M; Anwar R; Graham A; Smith JC; Markham AF
    Lancet; 1989 Dec 23-30; 2(8678-8679):1481-3. PubMed ID: 2574768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between haplotypes and specific mutations in Swiss cystic fibrosis families.
    Liechti-Gallati S; Malik N; Alkan M; Maechler M; Morris M; Thonney F; Sennhauser F; Moser H
    Pediatr Res; 1991 Oct; 30(4):304-8. PubMed ID: 1683481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Direct diagnosis of predominant mutation delta F508 associated with the mucoviscidosis gene].
    Férec C; Guillermit H; Verlingue C; Parent P; Puissant H; Jehanne M; Saleun JP
    Arch Fr Pediatr; 1990; 47(7):507-10. PubMed ID: 2256790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian analysis and risk assessment in genetic counseling and testing.
    Ogino S; Wilson RB
    J Mol Diagn; 2004 Feb; 6(1):1-9. PubMed ID: 14736820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of carriers by screening for delta F508 deletion in a multi-generation cystic fibrosis family.
    Claustres M; Desgeorges M; Kjellberg P; Demaille J
    Genet Couns; 1990; 1(3-4):211-7. PubMed ID: 1982988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis deletion mutation detected by PCR-mediated site-directed mutagenesis.
    Friedman KJ; Highsmith WE; Prior TW; Perry TR; Silverman LM
    Clin Chem; 1990 Apr; 36(4):695-6. PubMed ID: 2323051
    [No Abstract]   [Full Text] [Related]  

  • 15. Linked marker haplotypes and the delta F508 mutation in adults with mild pulmonary disease and cystic fibrosis.
    Santis G; Osborne L; Knight RA; Hodson ME
    Lancet; 1990 Jun; 335(8703):1426-9. PubMed ID: 1972211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis carrier testing in early pregnancy by general practitioners.
    Harris H; Scotcher D; Hartley N; Wallace A; Craufurd D; Harris R
    BMJ; 1993 Jun; 306(6892):1580-3. PubMed ID: 8329921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid nonradioactive detection of the major cystic fibrosis mutation.
    Rommens J; Kerem BS; Greer W; Chang P; Tsui LC; Ray P
    Am J Hum Genet; 1990 Feb; 46(2):395-6. PubMed ID: 2301405
    [No Abstract]   [Full Text] [Related]  

  • 18. XV-2c/KM19 haplotypes analysis of cystic fibrosis patients from western Mexico.
    Flores-Martínez SE; Martínez JF; Machorro-Lazo MV; García-Zapién AG; Salgado-Goytia L; Cruz-Quevedo EG; Morán-Moguel MC; Sánchez-Corona J
    Acta Physiol Hung; 2008 Sep; 95(3):313-25. PubMed ID: 18788470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct marketing of cystic fibrosis carrier screening: commercial push or population need?
    Cuckle H; Lilford R; Wilson J; Sehmi I
    J Med Genet; 1995 Sep; 32(9):758. PubMed ID: 8544204
    [No Abstract]   [Full Text] [Related]  

  • 20. Cystic fibrosis carrier screening. Are nurses ready to be on the front line?
    Tinkle MB
    AWHONN Lifelines; 2002; 6(2):134-9. PubMed ID: 11975127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.